Yahoo Web Search

    • Royalty Pharma Reports Second Quarter 2021 Results

      StreetInsider· 3 days ago

      Strong growth in net cash provided by operating activities (GAAP) and Adjusted Cash Flow(2)Announced transactions of up to $2.8 billion in 2021, including $2.1 billion* in upfront paymentsIncreased 2021 guidance: Adjusted Cash Receipts(1) expected to

    • Eli Lilly and Company Reaffirms Buy (LLY)

      Eli Lilly and Company Reaffirms Buy (LLY)

      Yahoo Finance· 2 years ago

      The company launched Emgality (galcanezumab), for the prevention of migraine, in 3Q18. Emgality's uptake should be boosted by its recent approval as a...